- Home
- NLOP vs LAB Comparison
NLOP vs LAB Comparison
Compare NLOP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLOP
- LAB
- Stock Information
- Founded
- NLOP N/A
- LAB 1999
- Country
- NLOP United States
- LAB United States
- Employees
- NLOP N/A
- LAB N/A
- Industry
- NLOP
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- NLOP
- LAB Industrials
- Exchange
- NLOP Nasdaq
- LAB Nasdaq
- Market Cap
- NLOP 498.8M
- LAB 473.2M
- IPO Year
- NLOP N/A
- LAB 2011
- Fundamental
- Price
- NLOP $33.12
- LAB $1.23
- Analyst Decision
- NLOP Strong Buy
- LAB Buy
- Analyst Count
- NLOP 1
- LAB 2
- Target Price
- NLOP $46.00
- LAB $2.50
- AVG Volume (30 Days)
- NLOP 104.6K
- LAB 1.4M
- Earning Date
- NLOP 01-01-0001
- LAB 08-11-2025
- Dividend Yield
- NLOP 1.03%
- LAB N/A
- EPS Growth
- NLOP N/A
- LAB N/A
- EPS
- NLOP N/A
- LAB N/A
- Revenue
- NLOP $117,598,000.00
- LAB $172,271,000.00
- Revenue This Year
- NLOP N/A
- LAB N/A
- Revenue Next Year
- NLOP N/A
- LAB $12.18
- P/E Ratio
- NLOP N/A
- LAB N/A
- Revenue Growth
- NLOP N/A
- LAB 26.39
- 52 Week Low
- NLOP $26.10
- LAB $0.92
- 52 Week High
- NLOP $34.53
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- NLOP 49.56
- LAB 43.04
- Support Level
- NLOP $32.45
- LAB $1.15
- Resistance Level
- NLOP $34.24
- LAB $1.37
- Average True Range (ATR)
- NLOP 0.75
- LAB 0.07
- MACD
- NLOP -0.06
- LAB -0.02
- Stochastic Oscillator
- NLOP 36.01
- LAB 26.67
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.